The present invention relates to the three dimensional structure of human collagenase
3 (MMP-13), as well as to (i) methods of using the MMP-13 structure to rationally
design or identify compounds or molecules that inhibit or activate MMP-13 activity,
and (ii) compounds identified using said methods.